ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Annals of Diagnostic Pathology
Volume 2, Issue 6, December 1998, Pages 401-421
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Purchase PDF (30712 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/S1092-9134(98)80042-7    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 1998 Published by Elsevier Inc.

Review article

Synovial sarcoma

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

MDCyril FisherCorresponding Author Contact Information

Royal Marsden NHS Trust, London, UK


Available online 7 December 2004.

Synovial sarcoma is a rare soft tissue tumor of children and adults that is unrelated to synovium and can occur in almost any part of the body. The familiar biphasic synovial sarcoma has discernible glandular or solid epithelial structures, and monophasic forms have characteristic ovoid or spindle cells with only immunohistochemical or ultrastructural evidence of epithelial differentiation. There are several morphologic patterns, including myxoid and hemangiopericytic, and behaviorally distinct calcifying, ossifying, and poorly differentiated subtypes can be recognized. Most synovial sarcomas are immunoreactive for cytokeratin, epithelial membrane antigen, and bc12 protein, and negative for CD34, and many express S100 protein and CD99 (MIC2). Nearly all synovial sarcomas have a specific t(x;18) (p11.2;q11.2) chromosomal abnormality, resulting in fusion of either of two variants of the SSX gene with the SYT gene; the genetic features may relate to morphology and outcome. The differential diagnosis can include a wide range of spindled, polygonal, or round cell sarcomas. Clinically, there have been marked recent improvements in local control of disease and lesser ones in management of metastases. The pathology, differential diagnosis, and behavior of this unique tumor are reviewed.


Corresponding Author Contact InformationAddress reprint requests to Cyril Fisher, MD, Royal Marsden NHS Trust, Fulham Rd, London, SW3 6JJ UK.

Annals of Diagnostic Pathology
Volume 2, Issue 6, December 1998, Pages 401-421
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.